[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,390
Citations 0
Correction
June 2015

Incorrect MACE End Point

JAMA Intern Med. 2015;175(6):1070. doi:10.1001/jamainternmed.2015.2214

In the article titled “Association of β-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery: A Danish Nationwide Cohort Study,” published online November 18, 2013, and also in the March 2014 issue of JAMA Internal Medicine (2014;174[3]:336-344. doi:10.1001/jamainternmed.2013.11349), an error ocurred in one part of the composite major cardiovascular adverse events (MACE) end point. All analyses were recalculated after correction of the end point, and the values were substantially unaltered. More important, none of the study’s conclusions were affected. This article was corrected online.

×